Cargando…

Analysis of tear film in cystinosis patients treated with topical viscous cysteamine hydrochloride (Cystadrops(®))

PURPOSE: The aim of this study was to evaluate in vivo the tear film in infantile nephropathic cystinosis patients with corneal crystals treated with topical viscous cysteamine hydrochloride (Cystadrops(®)). METHODS: Ten eyes of five patients with nephropathic cystinosis aged from 10 to 35 years wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sergio, Petroni, Giancarlo, Iarossi, Matteo, Federici, Maria, De Sanctis Carlo, Gianni, Petrocelli, Parrilla, Rosa, Valente, Paola, Luca, Buzzonetti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527349/ https://www.ncbi.nlm.nih.gov/pubmed/35125035 http://dx.doi.org/10.1177/11206721221078649

Ejemplares similares

Refractive outcome of keratoconus treated by big-bubble deep anterior lamellar keratoplasty in pediatric patients: two-year follow-up comparison between mechanical trephine and femtosecond laser assisted techniques
por: Buzzonetti, Luca, et al.
Publicado: (2019)

Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride
por: Liang, Hong, et al.
Publicado: (2021)

Importance of adherence to topical cysteamine in infantile ocular cystinosis: An illustrative case
por: Bayram-Suverza, Mauricio, et al.
Publicado: (2022)

Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report
por: Valente, Paola, et al.
Publicado: (2020)

Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients
por: Klank, Sabrina, et al.
Publicado: (2023)

Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
por: Bouazza, Naïm, et al.
Publicado: (2011)

Effects of long-term cysteamine treatment in patients with cystinosis
por: Ariceta, Gema, et al.
Publicado: (2017)

Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review
por: Makuloluwa, Achini K, et al.
Publicado: (2018)

Cysteamine–bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis
por: Jamalpoor, Amer, et al.
Publicado: (2021)

Cystinosis: Therapy adherence and metabolic monitoring in patients treated with immediate-release cysteamine
por: Linden, Simone, et al.
Publicado: (2020)

Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to “A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis”)
por: Langman, Craig B.
Publicado: (2023)

A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis
por: van Stein, Christina, et al.
Publicado: (2021)

A new proof of evidence of cysteamine quantification for therapeutic drug monitoring in patients with cystinosis
por: Franzin, Martina, et al.
Publicado: (2022)

A monoclinic polymorph of cysteamine hydrochloride
por: Ahmad, Saeed, et al.
Publicado: (2009)

Femtosecond Laser and Big-Bubble Deep Anterior Lamellar Keratoplasty: A New Chance
por: Buzzonetti, Luca, et al.
Publicado: (2012)

Cysteamine (Cystagon®) adherence in patients with cystinosis in Spain: successful in children and a challenge in adolescents and adults
por: Ariceta, Gema, et al.
Publicado: (2015)

Recent Research in Ocular Cystinosis: Drug Delivery Systems, Cysteamine Detection Methods and Future Perspectives
por: Castro-Balado, Ana, et al.
Publicado: (2020)

Response to Cysteamine in Osteoclasts Obtained from Patients with Nephropathic Cystinosis: A Genotype/Phenotype Correlation
por: Quinaux, Thomas, et al.
Publicado: (2021)

Genistein improves renal disease in a mouse model of nephropathic cystinosis: a comparison study with cysteamine
por: De Leo, Ester, et al.
Publicado: (2022)

Impact of compliance to oral cysteamine treatment on the costs of Kidney failure in patients with nephropathic cystinosis in the United Kingdom
por: Lashilola, Seun, et al.
Publicado: (2023)

In vivo confocal microscopy and anterior segment optical coherence tomography follow-up of cysteamine treatment in corneal cystinosis
por: Ozdemir, Huseyin Baran, et al.
Publicado: (2019)

A novel sustained‐release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers
por: Berends, Cécile L., et al.
Publicado: (2021)

Effectiveness of hyaluronic acid and arnica extract ophthalmic solution in reducing dry eye symptoms in pediatric population
por: Buzzonetti, Luca, et al.
Publicado: (2022)

Quality of Life is Improved and Kidney Function Preserved in Patients with Nephropathic Cystinosis Treated for 2 Years with Delayed-Release Cysteamine Bitartrate
por: Langman, Craig B., et al.
Publicado: (2014)

The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series
por: Biswas, Susmito, et al.
Publicado: (2018)

Ophthalmic Outcome in a Belgian Cohort of Cystinosis Patients Treated with a Compounded Preparation of Cysteamine Eye Drops: Retrospective Analysis
por: Peeters, Freya, et al.
Publicado: (2019)

The effects of transitioning from immediate release to extended release cysteamine therapy in Norwegian patients with nephropathic cystinosis: a retrospective study
por: Bjerre, Anna, et al.
Publicado: (2023)

A Novel Autosomal Recessive Variant of the NRL Gene Causing Enhanced S-Cone Syndrome: A Morpho-Functional Analysis of Two Unrelated Pediatric Patients
por: Iarossi, Giancarlo, et al.
Publicado: (2022)

A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis
por: Armas, Danielle, et al.
Publicado: (2018)

Human and animal fertility studies in cystinosis reveal signs of obstructive azoospermia, an altered blood‐testis barrier and a subtherapeutic effect of cysteamine in testis
por: Reda, Ahmed, et al.
Publicado: (2021)

Effects of coated cysteamine hydrochloride on muscle fiber characteristics and amino acid composition of finishing pigs
por: Bai, Miaomiao, et al.
Publicado: (2019)

Omeprazole treatment manifests anxiolytic effects in a cysteamine hydrochloride induced mouse model of gastrointestinal disorder
por: Sri Rethinavel, Harini, et al.
Publicado: (2022)

Superficial and Deep Capillary Plexuses: Potential Biomarkers of Focal Retinal Defects in Eyes Affected by Macular Idiopatic Epiretinal Membranes? A Pilot Study
por: Coppe, Andrea Maria, et al.
Publicado: (2022)

Fertility in Cystinosis
por: Reda, Ahmed, et al.
Publicado: (2021)

The TGM2 inhibitor cysteamine hydrochloride does not impact corneal epithelial and stromal wound healing in vitro and in vivo
por: Minella, A.L., et al.
Publicado: (2023)

Dietary stimulation of the endogenous somatotropic axis in weaner and grower-finisher pigs using medium chain triglycerides and cysteamine hydrochloride
por: Miller, David W., et al.
Publicado: (2016)

Cystinosis: a review
por: Elmonem, Mohamed A., et al.
Publicado: (2016)

Pregnancy in women with cystinosis
por: Blakey, Hannah, et al.
Publicado: (2019)

Evaluation of topical cysteamine therapy in the CTNS(−/−) knockout mouse using in vivo confocal microscopy
por: Simpson, Jennifer L., et al.
Publicado: (2011)

Inner Macular Changes in Fellow Eye of Patients With Unilateral Idiopathic Epiretinal Membrane
por: Coppe, Andrea M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k8vl0ap86sk7n8v8lr3tr74316